Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety Disorder (GOLD)
This study has been completed.
Study NCT00329446. Last updated on March 24, 2009.
Information provided by AstraZeneca
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Generalized Anxiety Disorder
Additional conditions recognized in this trial
Anxiety Disorders
Disease
More general conditions related to this trial
Mental Disorders
Pathologic Processes
Interventions listed in this trial
Quetiapine Fumarate
Escitalopram oxylate
Additional drug interventions recognized in this trial
Citalopram
Quetiapine
More general drug interventions related to this trial
Antidepressive Agents
Antidepressive Agents, Second-Generation
Antipsychotic Agents
Central Nervous System Agents
Central Nervous System Depressants
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
AstraZeneca
Back to top of Main Content